Access to Innovative Oncology Drugs in Europe
Madrid, Spain, 7 & 8 September 2017
The CDDF multi-stakeholder workshop on the Access to Innovative Oncology Drugs in Europe aims at facilitating a collaborative discussion between regulatory bodies, HTA organizations, healthcare providers, academics, patients and industry on the challenges of equal access to oncology drugs within and between European countries.
Who should attend?
Representatives from Academia, European Regulatory Bodies (HTA and EMA), Policymakers, Pharmaceutical Industry, Patient Associations and Payers.